EDGAR Filing Documents for 0001618835-20-000226

Form 8-K - Current report:

SEC Accession No. 0001618835-20-000226

Filing Date

2020-10-15

Accepted

2020-10-15 08:05:18

Documents

Period of Report

2020-10-14

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	evfm8-kadjuvantconvertible.htm	8-K	44132
2	EXHIBIT 10.1	evfm-ex101xsecuritiespurch.htm	EX-10.1	185488
3	EXHIBIT 10.2	evfm-ex102xformofnote2020a.htm	EX-10.2	26868
4	EXHIBIT 10.3	evfm-ex103xregistrationrig.htm	EX-10.3	115173
5	EXHIBIT 10.4	evfm-ex104xconvertpipexsid.htm	EX-10.4	129101
6	EXHIBIT 99.1	exhibit991adjuvantpressrel.htm	EX-99.1	19199
7		evofembiosciencesjpegfilea53.jpg	GRAPHIC	61097
	Complete submission text file	0001618835-20-000226.txt		605527

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130

Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900

Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)